التهاب الأوعية التكسري المحدود بالجلد المستمر بعد إدارة محفز الدواء أو العدوى

References

DOI: 10.1093/rheumatology/keac115

• If LCV is limited to the skin, the management strategy should mostly focus on symptomatic relief, since the majority of acute episodes of cutaneous SVV are self-limited and do not recur, even without treatment.
• When the cause of LCV is obvious, such as infections or drugs, eliminating or treating the trigger whenever possible is crucial and often sufficient.
• On the opposite, when a skin-limited SVV is severe, intractable or recurrent, the treatment should generally include systemic corticosteroids with or without adjunctive therapies.
• The response to steroid therapy is usually rapid, but the dose should be tapered slowly to prevent rebound.
• Colchicine improved skin and joint symptoms in open label studies, inducing prompt resolution of cutaneous vasculitis.